Franklin Street Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $945K | Hold |
7,476
| – | – | 0.05% | 85 |
|
|
2026
Q1 | $1.04M | Buy |
7,476
+24
| +0.3% | +$3.36K | 0.06% | 81 |
|
|
2025
Q4 | $915K | Hold |
7,452
| – | – | 0.05% | 87 |
|
|
2025
Q3 | $827K | Sell |
7,452
-100
| -1% | -$11.4K | 0.05% | 84 |
|
|
2025
Q2 | $837K | Hold |
7,552
| – | – | 0.05% | 91 |
|
|
2025
Q1 | $846K | Buy |
7,552
+602
| +9% | +$62.1K | 0.06% | 90 |
|
|
2024
Q4 | $642K | Hold |
6,950
| – | – | 0.04% | 100 |
|
|
2024
Q3 | $583K | Hold |
6,950
| – | – | 0.04% | 101 |
|
|
2024
Q2 | $477K | Sell |
6,950
-623
| -8% | -$41.6K | 0.03% | 111 |
|
|
2024
Q1 | $555K | Sell |
7,573
-300
| -4% | -$23.1K | 0.04% | 98 |
|
|
2023
Q4 | $638K | Hold |
7,873
| – | – | 0.05% | 89 |
|
|
2023
Q3 | $590K | Hold |
7,873
| – | – | 0.05% | 90 |
|
|
2023
Q2 | $607K | Buy |
7,873
+300
| +4% | +$23.9K | 0.05% | 92 |
|
|
2023
Q1 | $628K | Hold |
7,573
| – | – | 0.06% | 90 |
|
|
2022
Q4 | $650K | Hold |
7,573
| – | – | 0.06% | 90 |
|
|
2022
Q3 | $467K | Sell |
7,573
-265
| -3% | -$16.7K | 0.05% | 97 |
|
|
2022
Q2 | $484K | Sell |
7,838
-130
| -2% | -$8.05K | 0.05% | 102 |
|
|
2022
Q1 | $474K | Sell |
7,968
-145
| -2% | -$9.27K | 0.04% | 111 |
|
|
2021
Q4 | $589K | Sell |
8,113
-549
| -6% | -$37.8K | 0.04% | 108 |
|
|
2021
Q3 | $605K | Sell |
8,662
-2,502
| -22% | -$176K | 0.05% | 101 |
|
|
2021
Q2 | $769K | Sell |
11,164
-100
| -0.9% | -$6.68K | 0.07% | 89 |
|
|
2021
Q1 | $728K | Buy |
11,264
+100
| +0.9% | +$6.45K | 0.07% | 92 |
|
|
2020
Q4 | $650K | Sell |
11,164
-1,750
| -14% | -$106K | 0.06% | 92 |
|
|
2020
Q3 | $816K | Buy |
12,914
+850
| +7% | +$58.9K | 0.09% | 81 |
|
|
2020
Q2 | $928K | Sell |
12,064
-95
| -0.8% | -$7.28K | 0.11% | 74 |
|
|
2020
Q1 | $909K | Buy |
12,159
+430
| +4% | +$29.7K | 0.13% | 72 |
|
|
2019
Q4 | $762K | Sell |
11,729
-596
| -5% | -$38.8K | 0.09% | 88 |
|
|
2019
Q3 | $781K | Sell |
12,325
-100
| -0.8% | -$6.54K | 0.1% | 84 |
|
|
2019
Q2 | $839K | Buy |
12,425
+1,495
| +14% | +$98.3K | 0.11% | 82 |
|
|
2019
Q1 | $711K | Sell |
10,930
-115
| -1% | -$7.64K | 0.1% | 87 |
|
|
2018
Q4 | $691K | Sell |
11,045
-105,963
| -91% | -$7.41M | 0.11% | 88 |
|
|
2018
Q3 | $9.03M | Buy |
117,008
+3,126
| +3% | +$236K | 1.22% | 33 |
|
|
2018
Q2 | $8.07M | Buy |
113,882
+320
| +0.3% | +$22.6K | 1.18% | 36 |
|
|
2018
Q1 | $8.56M | Buy |
113,562
+1,515
| +1% | +$120K | 1.28% | 31 |
|
|
2017
Q4 | $8.03M | Buy |
112,047
+6,212
| +6% | +$472K | 1.2% | 33 |
|
|
2017
Q3 | $8.57M | Buy |
105,835
+40,080
| +61% | +$3.06M | 1.41% | 22 |
|
|
2017
Q2 | $4.65M | Sell |
65,755
-3,840
| -6% | -$256K | 0.8% | 51 |
|
|
2017
Q1 | $4.73M | Sell |
69,595
-41,748
| -37% | -$2.94M | 0.83% | 52 |
|
|
2016
Q4 | $7.97M | Sell |
111,343
-109,459
| -50% | -$8.14M | 1.41% | 20 |
|
|
2016
Q3 | $17.5M | Buy |
220,802
+2,756
| +1% | +$224K | 3.18% | 3 |
|
|
2016
Q2 | $18.2M | Buy |
218,046
+635
| +0.3% | +$56.4K | 3.45% | 2 |
|
|
2016
Q1 | $20M | Buy |
217,411
+12,758
| +6% | +$1.15M | 3.95% | 2 |
|
|
2015
Q4 | $20.7M | Sell |
204,653
-1,690
| -0.8% | -$176K | 4.07% | 2 |
|
|
2015
Q3 | $20.3M | Buy |
206,343
+1,156
| +0.6% | +$128K | 4.02% | 2 |
|
|
2015
Q2 | $24M | Buy |
205,187
+1,035
| +0.5% | +$113K | 4.3% | 2 |
|
|
2015
Q1 | $20M | Sell |
204,152
-3,515
| -2% | -$357K | 3.67% | 2 |
|
|
2014
Q4 | $19.6M | Buy |
207,667
+1,410
| +0.7% | +$146K | 3.73% | 2 |
|
|
2014
Q3 | $22M | Buy |
206,257
+36,820
| +22% | +$3.61M | 4.17% | 2 |
|
|
2014
Q2 | $14M | Sell |
169,437
-1,788
| -1% | -$139K | 2.68% | 4 |
|
|
2014
Q1 | $12.1M | Sell |
171,225
-1,486
| -0.9% | -$117K | 2.43% | 6 |
|
|
2013
Q4 | $13M | Buy |
172,711
+832
| +0.5% | +$57.9K | 2.62% | 3 |
|
|
2013
Q3 | $10.8M | Sell |
171,879
-3,100
| -2% | -$185K | 2.42% | 4 |
|
|
2013
Q2 | $8.97M | Buy |
+174,979
| New | +$9.12M | 2.2% | 5 |
|
Other funds holding GILD
Franklin Street Advisors's GILD Position: Q2 2026 in Review
Franklin Street Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 7,476 shares worth $945K. The position accounts for 0.05% of the portfolio, ranked #85.
Franklin Street Advisors first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $24M in Q2 2015. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Franklin Street Advisors held 7,476 shares of Gilead Sciences worth $945K as of Q2 2026.
- Franklin Street Advisors left its Gilead Sciences share count unchanged in Q2 2026.
- Gilead Sciences made up 0.05% of Franklin Street Advisors's portfolio in Q2 2026, its #85 holding.
- Franklin Street Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Franklin Street Advisors's Gilead Sciences position peaked at $24M in Q2 2015.
- 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Franklin Street Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.